Five Verrill Dana Attorneys Elected as Partners of the Firm

January 14, 2016 Press Releases

(1/14/16) Verrill Dana is proud to announce that attorneys Janet Britton, Katie Gray, Kate Heffernan, Sara Hirshon and Andrew Rusczek have been elected partners of the firm.

Janet Britton joined Verrill Dana's Labor & Employment Group as Counsel in April of 2013 and is based in the Portland Office. She advises business clients of all sizes in a wide variety of labor and employment matters such as: personnel policies, hiring and firing, anti-discrimination laws, employee manuals, the Family Medical Leave Act, the Fair Labor Standards Act, reductions in force, and related business contract matters. She started her legal career as Associate Counsel at Wright Express, now WEX, and later worked in the legal department of Delhaize America. Janet received a Bachelor of Arts degree from the University of Southern Maine and her law degree from the University of Maine School of Law.

Katie Gray joined Verrill Dana's Energy and Utilities Group in March of 2009 and is based in the Portland office. She has worked on a number of large energy projects and counseled utility, industrial and university clients. Katie was a Summer Associate with Verrill Dana in 2007 and joined the firm in the fall of 2008. Katie received her undergraduate degree, summa cum laude, from University of Maine, and her J.D. from Boston University School of Law.

Kate Gallin Heffernan joined Verrill Dana's Health Care Group as Counsel in 2013 and is based in the Boston office. She serves as Chair of the firm's Academic and Clinical Research Group and as the editor of that group's recently launched blog, Endpoints, After law school, Kate clerked for the Honorable Dennis Jacobs on the United States Court of Appeals for the Second Circuit. She worked as an Associate in the Health Care Group at Ropes & Gray LLP in Boston before joining the Office of the General Counsel at Partners HealthCare System. Prior to joining Verrill Dana, Kate operated her own legal practice (KGH Advisors, LLC). She received her undergraduate degree, magna cum laude, from Georgetown University, and her J.D., magna cum laude, from New York University School of Law.

Sara Hirshon joined Verrill Dana in 2010 and serves clients from Verrill Dana's Boston and Portland offices. Her practice focuses on complex commercial litigation matters as well as a variety of IP matters including litigation related to copyright, trademark, and trade infringement. In addition to litigation work, she often assists clients in protecting their brands outside of litigation and spearheaded the formation of Verrill Dana's Fashion & Design Law Group. Prior to joining Verrill Dana, Sara worked at law firms in Boston and Philadelphia. She received her B.A., with honors, from the University of Michigan and her J.D. from Boston University.

Andrew Rusczek joined Verrill Dana's Health Care Group in August of 2012 and is based in the Boston office. He works extensively as a member of the firm's Academic and Clinical Research, and Biopharma & Medical Device Groups. Prior to joining Verrill Dana, he worked as an Associate at Ropes & Gray LLP in Boston. Andy received his undergraduate degree, magna cum laude, from Bowdoin College. He received his J.D , cum laude, from the University of Pennsylvania Law School and his Master of Bioethics, from the University of Pennsylvania School of Medicine.

Firm Highlights


FDA Issues Guidance on IRB Review of Non-Emergency Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products to Treat COVID-19

Prompted by a substantial increase in requests for individual patient access to investigational drugs and biologics to treat COVID-19, the U.S. Food & Drug Administration (“FDA”) issued guidance on June 2, 2020 that outlines...


Common Rule

Guided multiple clients through the implementation of the revised HHS regulations (the "Common Rule"), including reviewing and revising policies and procedures, and assisting with institutional approaches to implementation.


Responsible Research During the COVID-19 Pandemic


Conflicts of Interest

Reviewed medical center's systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.


COVID-19 Expanded Access Template

We are aware that many companies and health care providers are working to expedite the transfer of investigational drugs that may be helpful in treating patients suffering from COVID-19. Although these expanded access arrangements...


News Flash: HHS Issues Statement Removing Premarket Review Requirements for Laboratory Developed Tests (“LDTs”), Including COVID-19 LDTs

What happened? On August 19, 2020, the U.S. Department of Health and Human Services (“HHS”) issued a single paragraph statement rescinding U.S. Food and Drug Administration (“FDA”) guidance documents concerning premarket review of Laboratory...


Research Non-Compliance Investigations

Test Tubes

Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...


FDA Announces New Updates to its Guidance on Conducting Clinical Trials During COVID-19 and Notes Availability of its COVID MyStudies App

On June 3, 2020, the U.S. Food & Drug Administration (“FDA”) again updated its guidance on the “ Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency ” with new information...


European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...